ALBERT LABS INTL. CORP. Aktie - Unternehmensdaten & Kurse - CA0127841041 | MoneyPeak

ALBERT LABS INTL. CORP.

Share · CA0127841041 · A3DJEF (XCNQ)

No Price

n/a

Share Float & Liquidity

Free Float 99,62 %

Shares Float 74,13 M

Shares Outstanding 74,41 M

Company Profile for ALBERT LABS INTL. CORP. Share

Albert Labs International Corp. operates as a clinical research and drug development company. The company focuses on treating patients with urgent and unmet needs, including critical mental health indications. It develops psilocybin-assisted therapies to improve mental health conditions, including anxiety, depression, and oncology-related distress. The company is based in Burnaby, Canada.

Get up to date insights from finAgent about ALBERT LABS INTL. CORP.

Company Data

Name ALBERT LABS INTL. CORP.

Company Albert Labs International Corp.

Website https://albertlabs.com

Primary Exchange

Frankfurt

WKN A3DJEF

ISIN CA0127841041

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Navchand Jagpal

Country Canada

Currency EUR

Employees -

Address 6996 Merritt Avenue, V5J 4R6 Burnaby

IPO Date 2023-02-01

Ticker Symbols

Name	Symbol
CSE LISTED	ABRT.CN
Frankfurt	VB50.F

More Shares

Investors who hold ALBERT LABS INTL. CORP. also have the following shares in their portfolio:

KASIKANK -FGN- BA 10 Share

Kesar Petroproducts Limited Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025